Nascent Biotech, Inc.
OTC:NBIO
0.2 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 1 | 0.75 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.32 | 0 | 1 | 0.75 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0.203 | 0.654 | 0.197 | 0.322 | 0.294 | 0.254 | 1.195 | 0.487 | 1.15 | 1.675 | 0.384 | 0.381 |
| General & Administrative Expenses
| 1.707 | 1.486 | 0.927 | 1.828 | 3.154 | 1.115 | 1.027 | 1.565 | 4.294 | 0.47 | 0.187 | 0.292 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.707 | 0.39 | 0.927 | 1.828 | 3.154 | 1.115 | 1.027 | 1.565 | 4.294 | 0.47 | 0.187 | 0.292 |
| Other Expenses
| 0 | 0 | 0.332 | 0 | 0 | 0 | 0 | -0.48 | 0 | -0.02 | 1.34 | 0 |
| Operating Expenses
| 1.91 | 2.14 | 1.457 | 2.15 | 3.447 | 1.369 | 2.222 | 1.573 | 5.444 | 2.128 | 1.906 | 0.674 |
| Operating Income
| -2.23 | -2.156 | -0.457 | -1.4 | -3.447 | -1.369 | -2.222 | 1.427 | -5.444 | -2.123 | -0.571 | -0.674 |
| Operating Income Ratio
| 0 | 0 | -0.457 | -1.867 | 0 | 0 | 0 | 0.476 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.142 | -0.645 | -0.013 | 0.442 | -0.557 | 0 | 0 | -0.05 | -0.278 | -0.029 | -1.346 | -0.015 |
| Income Before Tax
| -2.088 | -2.801 | -0.47 | -0.959 | -4.004 | -1.369 | -2.221 | 1.377 | -4.149 | -2.152 | -1.918 | -0.689 |
| Income Before Tax Ratio
| 0 | 0 | -0.47 | -1.279 | 0 | 0 | 0 | 0.459 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0.24 | -0 | 0.006 | 0 | 0.03 |
| Net Income
| -2.088 | -2.801 | -0.47 | -0.959 | -4.091 | -1.369 | -2.221 | 1.137 | -4.149 | -2.152 | -1.918 | -0.689 |
| Net Income Ratio
| 0 | 0 | -0.47 | -1.279 | 0 | 0 | 0 | 0.379 | 0 | 0 | 0 | 0 |
| EPS
| -0.013 | -0.024 | -0.004 | -0.01 | -0.12 | -0.046 | -0.086 | 0.05 | -0.21 | -0.15 | -0.61 | -0.26 |
| EPS Diluted
| -0.013 | -0.024 | -0.004 | -0.01 | -0.12 | -0.046 | -0.086 | 0.05 | -0.21 | -0.15 | -0.61 | -0.26 |
| EBITDA
| 0.527 | 0 | -0.134 | -0.622 | -0.47 | 0 | 0 | 1.431 | 0 | -2.144 | -0.57 | -0.625 |
| EBITDA Ratio
| 0 | 0 | -0.134 | -0.829 | 0 | 0 | 0 | 0.477 | 0 | 0 | 0 | 0 |